Estonia's transport authority has approved Tesla's FSD (Full Self-Driving) driver-assistance system for use on its roads, recognizing a type approval initially granted in the Netherlands. Tesla announced on X that the rollout will begin soon. The authority clarified that FSD is a Level 2 driver assistance system, meaning the driver remains fully responsible and must be prepared to take control at all times.

Cisco CEO Chuck Robbins revealed that the company's significant role in the current AI buildout stems from a silicon company acquisition made in 2016, long before AI gained mainstream attention. This strategic move provided Cisco with critical networking silicon, a key competitive advantage for connecting large AI clusters. Ironically, while Cisco aimed to shift towards software and recurring revenue, the AI boom has emphasized hardware, underscoring that many AI winners had laid foundational groundwork years in advance.

Duke Energy Florida is implementing its third rate reduction of 2026, which will decrease residential customer bills by approximately $50, or 25%, for every 1,000 kilowatt-hours used, when compared to January levels. This reduction is attributed to the early removal of storm cost recovery charges, a seasonal decrease to help with higher energy use periods, and a "true up" reflecting the difference between collected and incurred storm costs. Additionally, the company highlights ongoing efforts to create further savings through efficiency improvements in natural gas plants, new solar energy sites, and the passing on of Inflation Reduction Act tax credits.

Oracle's stock price increased by 6.39% due to a new multi-billion dollar cloud infrastructure deal with the US government for AI computing capacity. The company also raised its revenue guidance for fiscal year 2027, reflecting strong demand for its AI infrastructure and cloud offerings, and has received positive sentiment from financial analysts and increased institutional investor confidence. Despite these positives, Oracle faces risks including substantial net debt, lower profitability in its AI cloud operations, uncertainty in converting its RPO backlog, and significant restructuring costs from recent workforce reductions.

CVS Caremark announced it will reinstate Zepbound (tirzepatide) to its commercial formularies as a preferred option and remove the new-to-market block on Foundayo (orforglipron), effective October 1, 2026, and June 1, 2026, respectively. This move, stemming from negotiations with drug manufacturers, aims to expand GLP-1 access while managing costs and signals how PBMs might approach oral GLP-1 agents. The decision highlights ongoing affordability and access challenges for plan sponsors regarding weight-loss GLP-1s, with coverage often contingent on negotiated pricing concessions.

General Electric Co (GE) shares traded modestly higher on the NYSE after GE Aerospace announced a new U.S. Air Force GE426 engine design contract, keeping the stock in focus for future defense and aviation programs. The contract involves the preliminary design review of the GE426 engine for future military applications, extending GE Aerospace's relationship with the U.S. Department of Defense. Trading near its 52-week high, the stock's performance reflects optimism about the company's aerospace-focused strategy and its role as a key defense engine supplier.

Bell Textron Inc. announced the delivery of a new Bell 407GXi helicopter to the Texas Department of Public Safety (DPS), expanding their air operations fleet. This delivery marks a continuation of a nearly 60-year relationship between Bell and Texas DPS, enhancing the department's ability to support law enforcement, emergencies, and public safety across the state. The Bell 407GXi, known for its advanced technology and mission versatility, joins other Bell models previously operated by Texas DPS.

Bristol Myers Squibb announced positive Phase 3 results for its CELMoD mezigdomide, demonstrating a 52% reduction in the risk of disease progression or death in patients with relapsed or refractory multiple myeloma. The MeziKd combination showed a median progression-free survival of 18 months and a consistent safety profile. These findings bolster the potential of CELMoD therapies as a new standard of care and will be shared with health authorities.

Church & Dwight Co., Inc. has acquired Miss Mouth's Messy Eater brand for approximately $325 million. The brand, known for its fast-acting, nontoxic stain removal products, generated around $80 million in net sales and $28 million in EBITDA for the 12 months ending December 31, 2025. This acquisition is expected to be neutral to Church & Dwight's 2026 EPS but accretive to cash earnings in 2027, leveraging the brand's strong e-commerce presence and appeal among Millennial and Gen Z parents.

The Ultium Cells plant, jointly owned by General Motors and LG Energy Solution, has delayed the return of laid-off workers in Ohio until August due to weak demand for electric vehicles. Hundreds of employees were initially told to expect to return in June but received an internal announcement pushing the date back. The plant had previously laid off 850 workers temporarily and 480 permanently last fall, providing battery cells for GM's EVs.